A phase I single and multiple ascending dose study assessing AK-1780
Latest Information Update: 04 Feb 2021
At a glance
- Drugs AK 1780 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Asahi Kasei
- 04 Feb 2021 New trial record
Latest Information Update: 04 Feb 2021